Literature DB >> 21349253

Production and functions of IL-33 in the central nervous system.

Satoko Yasuoka1, Jun Kawanokuchi, Bijay Parajuli, Shijie Jin, Yukiko Doi, Mariko Noda, Yoshifumi Sonobe, Hideyuki Takeuchi, Tetsuya Mizuno, Akio Suzumura.   

Abstract

Interleukin-33 (IL-33) is a novel multifunctional IL-1 family cytokine. IL-33 signals via a heterodimer composed of IL-1 receptor-related protein ST2 and IL-1 receptor accessory protein (IL-1RAcP). IL-33 has been shown to activate T helper 2 cells (Th2), mast cells and basophils to produce a variety of Th2 cytokines and mediate allergic-type immune responses. Recent studies have revealed that glial cells are induced to express IL-33 mRNA and protein. However, the functions of IL-33 and its producing cells in the central nervous system (CNS) are still uncertain. In this study, we investigated the expression and function of IL-33 in the CNS. IL-33 is produced by endothelial cells and astrocytes but not by microglia or neurons. The IL-33 receptors are expressed mainly in microglia and astrocytes. IL-33 dose-dependently induces the proliferation of microglia and enhances the production of pro-inflammatory cytokines, such as IL-1β and TNFα, as well as the anti-inflammatory cytokine IL-10. It also enhances chemokines and nitric oxide production and phagocytosis by microglia. Thus, IL-33 produced in the CNS activates microglia and may function as a pro-inflammatory mediator in the pathophysiology of the CNS.
Copyright © 2010 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21349253     DOI: 10.1016/j.brainres.2011.02.045

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  74 in total

Review 1.  Research progress on interleukin-33 and its roles in the central nervous system.

Authors:  Ping Han; Wen-Li Mi; Yan-Qing Wang
Journal:  Neurosci Bull       Date:  2011-10       Impact factor: 5.203

2.  IL-33 Exerts Neuroprotective Effect in Mice Intracerebral Hemorrhage Model Through Suppressing Inflammation/Apoptotic/Autophagic Pathway.

Authors:  Yuan Gao; Lu Ma; Cheng-Liang Luo; Tao Wang; Ming-Yang Zhang; Xi Shen; Huan-Huan Meng; Meng-Meng Ji; Zu-Feng Wang; Xi-Ping Chen; Lu-Yang Tao
Journal:  Mol Neurobiol       Date:  2016-07-12       Impact factor: 5.590

Review 3.  Emerging role of interleukin-33 in autoimmune diseases.

Authors:  Cheng Pei; Mark Barbour; Karen J Fairlie-Clarke; Debbie Allan; Rong Mu; Hui-Rong Jiang
Journal:  Immunology       Date:  2014-01       Impact factor: 7.397

4.  Distinctive cytokine, chemokine, and antibody responses in Echinococcus multilocularis-infected patients with cured, stable, or progressive disease.

Authors:  Xiangsheng Huang; Beate Grüner; Christian J Lechner; Peter Kern; Peter T Soboslay
Journal:  Med Microbiol Immunol       Date:  2014-02-09       Impact factor: 3.402

Review 5.  The dual roles of cytokines in Alzheimer's disease: update on interleukins, TNF-α, TGF-β and IFN-γ.

Authors:  Cong Zheng; Xin-Wen Zhou; Jian-Zhi Wang
Journal:  Transl Neurodegener       Date:  2016-04-05       Impact factor: 8.014

6.  Cross-species evidence for the role of interleukin-33 in depression risk.

Authors:  Anastacia Y Kudinova; Terrence Deak; Cara M Hueston; John E McGeary; Valerie S Knopik; Rohan H C Palmer; Brandon E Gibb
Journal:  J Abnorm Psychol       Date:  2016-04-07

7.  Alzheimer's disease: evidence for the expression of interleukin-33 and its receptor ST2 in the brain.

Authors:  Zhi Xiong; Ramasamy Thangavel; Duraisamy Kempuraj; Evert Yang; Smita Zaheer; Asgar Zaheer
Journal:  J Alzheimers Dis       Date:  2014       Impact factor: 4.472

Review 8.  Tissue Engineering Approaches to Modulate the Inflammatory Milieu following Spinal Cord Injury.

Authors:  Courtney M Dumont; Daniel J Margul; Lonnie D Shea
Journal:  Cells Tissues Organs       Date:  2016-10-05       Impact factor: 2.481

9.  Induced interleukin-33 expression enhances the tumorigenic activity of rat glioma cells.

Authors:  Kuan-Min Fang; Chung-Shi Yang; Tzu-Chien Lin; Ti-Chun Chan; Shun-Fen Tzeng
Journal:  Neuro Oncol       Date:  2013-12-09       Impact factor: 12.300

10.  Associations of Circulating Growth Differentiation Factor-15 and ST2 Concentrations With Subclinical Vascular Brain Injury and Incident Stroke.

Authors:  Charlotte Andersson; Sarah R Preis; Alexa Beiser; Charles DeCarli; Kai C Wollert; Thomas J Wang; James L Januzzi; Ramachandran S Vasan; Sudha Seshadri
Journal:  Stroke       Date:  2015-07-28       Impact factor: 7.914

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.